Profile
| Metric | Value |
|---|---|
| Full Name | Lantheus Holdings, Inc. |
| Ticker | NASDAQ: LNTH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | lantheus.com |
| Employees | 808 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $67.27 | |
| Price, 1D Change | +1.08% | |
| Market Cap | $4B | |
| - | ||
| PE Ratio | 28.25 | |
| Beta | 0.47 | |
| Revenue | $2B | |
| Revenue, 1Y Change | +18.32% | |
| EPS | $4.36 | |
| EPS, 1Y Change | -6.24% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $4.36 | |
| EPS Estimate | $5.57 | |
| EPS Est. Change | +27.72% | |
| Revenue | $1.53B | |
| Revenue Estimate | $1.50B | |
| Revenue Est. Change | -2.03% | |
| Current Price | $67.27 | |
| Price Target | - | $80.50 |
| Price Tgt. Change | - | +19.67% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.94 | $4.65 | -21.71% | |
| $6.75 | $4.36 | -35.43% | |
| $5.57 | N/A | +27.72% | |
| $5.59 | N/A | +28.18% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.28B | $1.30B | +0.91% | |
| $1.52B | $1.53B | +0.91% | |
| $1.50B | N/A | -2.03% | |
| $1.51B | N/A | -1.71% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -24.25% | |
| Price, 3Y | +32.01% | |
| Market Cap, 1Y | -26.61% | |
| Market Cap, 3Y | +29.66% | |
| Revenue, 1Y | +18.32% | |
| Revenue, 3Y | +260.74% | |
| EPS, 1Y | -6.24% | |
| EPS, 3Y | +512.86% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $67.27 | |
| SMA 200 | $70.62 | |
| SMA 200 vs Price | +4.98% | |
| SMA 50 | $59.54 | |
| SMA 50 vs Price | -11.49% | |
| Beta | 0.47 | |
| ATR | $1.80 | |
| 14-Day RSI | 65.26 | |
| 10-Day Volatility | 23.65% | |
| 1-Year Volatility | 56.02% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.53B | |
| EPS | $4.36 | |
| Gross Profit | $988.29M | |
| Gross Margin | 64.43% | |
| Operating Profit | $445.87M | |
| Operating Margin | -6.50% | |
| Net Income | $312.44M | |
| Net Margin | 20.37% | |
| EBITDA | $510.49M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.57 | |
| Current Ratio | 5.52 | |
| Quick Ratio | 5.23 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 5.33 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 28.25 | |
| PS Ratio | 2.92 | |
| PB Ratio | 3.99 | |
| EV/EBITDA | 11.53 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.09B | |
| Cash & Equivalents | $912.81M | |
| Total Assets | $2.02B | |
| Current Assets | $1.33B | |
| Total Liabilities | $927.10M | |
| Current Liabilities | $240.53M | |
| Total Debt | $621.31M | |
| Short Term Debt | $2.84M | |
| Accounts Payable | $34.56M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.22B | |
| Operating Expenses | $542.43M | |
| Cost Of Goods Sold | $545.62M | |
| SG&A | $0.00 | |
| D&A | $64.62M | |
| Interest Expense | $0.00 | |
| Income Tax | $118.54M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $542.42M | |
| CFI | -$226.02M | |
| CFF | -$116.21M | |
| Capex | $79.63M | |
| Free Cash Flow | $462.79M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Truist Securities | → | |
| Mizuho | → | |
| Truist Securities | → | |
| Truist Securities | → | |
| Goldman Sachs | → | |
| B. Riley Securities | → | |
| TD Cowen | → | |
| Truist Securities | → | |
| Mizuho | → | |
| JMP Securities | → |
Analyst sentiment
Institutional ownership
Screeners with LNTH
Data Sources & References
- LNTH Official Website www.lantheus.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1521036/000119312525268113/0001193125-25-268113-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1521036/000162828025007970/0001628280-25-007970-index.htm
- LNTH Profile on Yahoo Finance finance.yahoo.com/quote/LNTH
- LNTH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lnth
FAQ
What is the ticker symbol for Lantheus Holdings, Inc.?
The ticker symbol for Lantheus Holdings, Inc. is NASDAQ:LNTH
Does Lantheus Holdings, Inc. pay dividends?
No, Lantheus Holdings, Inc. does not pay dividends
What sector is Lantheus Holdings, Inc. in?
Lantheus Holdings, Inc. is in the Healthcare sector
What industry is Lantheus Holdings, Inc. in?
Lantheus Holdings, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Lantheus Holdings, Inc. based in?
Lantheus Holdings, Inc. is headquartered in United States
When did Lantheus Holdings, Inc. go public?
Lantheus Holdings, Inc. initial public offering (IPO) was on June 25, 2015
Is Lantheus Holdings, Inc. in the S&P 500?
No, Lantheus Holdings, Inc. is not included in the S&P 500 index
Is Lantheus Holdings, Inc. in the NASDAQ 100?
No, Lantheus Holdings, Inc. is not included in the NASDAQ 100 index
Is Lantheus Holdings, Inc. in the Dow Jones?
No, Lantheus Holdings, Inc. is not included in the Dow Jones index
When was Lantheus Holdings, Inc. last earnings report?
Lantheus Holdings, Inc.'s most recent earnings report was on November 6, 2025
When does Lantheus Holdings, Inc. report earnings?
The next expected earnings date for Lantheus Holdings, Inc. is March 2, 2026